ストックスクリーナーアプリを入手
31.10
13.76%
3.71
アフターアワーズ：
31.00
-0.10
-0.32%
Hims Hers Health Inc (HIMS) 最新ニュース
Hims & Hers Health (NYSE:HIMS) Stock Price Up 10.8%What's Next? - MarketBeat
Hims & Hers Rejects Privacy Allegations While Promising Expanded Patient Access - Benzinga
Hims & Hers Health sees 17x international reven... - Pluang
Wellness Briefing: Hims & Hers plots rapid expansion into peptide therapies like BPC-157, plus news - glossy.co
Hims & Hers: Buying The Margin Dip (NYSE:HIMS) - Seeking Alpha
Berger Montague PC Investigates Hims & Hers Health, Inc.'s Board of Directors for Breach of Fiduciary Duty (HIMS) - marketscreener.com
Hims & Hers' Chief Accounting Officer Is Leaving. Here's What Her Latest Insider Filing Shows - The Motley Fool
An Insider at Hims & Hers Just Filed. Here's What It Says About Buying the Dip - The Motley Fool
A Hims & Hers Insider Disposed of Stock as the Company Pushes Into Testosterone and Peptides. Here's What to Know - The Motley Fool
An Insider at Hims & Hers Disposed of Over $3 Million in Stock. Here's What Long-Term Investors Should Know - The Motley Fool
The CTO of Hims & Hers Just Gave Up Nearly $2.7 Million in Stock. Here's What It Actually Means - The Motley Fool
What Long-Term Investors Should Know About This Hims Insider Filing - The Motley Fool
Hims & Hers' CEO Just Disposed of 78,859 Shares. Here's What Long-Term Investors Should Know. - The Motley Fool
An Insider at Hims & Hers Just Filed. Here's What It Says About Buying the Dip - The Motley Fool
Hims & Hers' Policy Chief Just Filed an Insider Transaction. Here's What It Means. - The Motley Fool
Companies with huge datasets can save up to 80% in AI costs by using open-weight models: Hims CEO - Business Insider
Hims & Hers Health Boosts Revenue Target, Swings to Second-Quarter Loss - wsj.com
Hims & Hers faces FTC lawsuit over privacy brea... - Pluang
Is Hims & Hers Health Inc (HIMS) a Bargain After 4.3% Drop? GF V - GuruFocus
Why Is Hims & Hers Health (HIMS) Facing A New Privacy Lawsuit? - Yahoo Finance
Oluyemi Okupe Sells 55,383 Shares of Hims & Hers Health (NYSE:HIMS) Stock - MarketBeat
Insider Selling: Hims & Hers Health (NYSE:HIMS) CFO Sells $261,831.32 in Stock - MarketBeat
Hims & Hers Health (NYSE: HIMS) Stock Plunges 14% Following - GlobeNewswire
Hims & Hers CEO Andrew Dudum Says AI Health Coach Could Be Just 12 Months Away, Believes It Could Increase Medication Adherence - Stocktwits
Kaplan Fox Announces an Investigation Into Hims & Hers Health, In - The National Law Review
Hims & Hers Health Options Spot-On: On August 18th, 65,547 Contracts Were Traded, With 886.89K Open Interest - moomoo.com
HIMS Looks 34.0% Undervalued on GF Value™ Despite Profitability Challenges - GuruFocus
Hims CEO responds to FTC suit, sees GLP-1 prices falling to $40-$50: CNBC - Seeking Alpha
Hims & Hers CEO Andrew Dudum pushes back on FTC lawsuit - qz.com
Hims & Hers CEO pushes back against FTC suit, says "we are active disruptors" - Investing.com Nigeria
Hims & Hers CEO Tells the FTC That Regulators Just Don’t Understand - Yahoo Finance
Hims & Hers CEO says FTC lawsuit misunderstands how the company works - CNBC
Hims & Hers: Eucalyptus Deal Unlocks New Markets (NYSE:HIMS) - Seeking Alpha
Hims & Hers Health Stock Short Interest Rises to 32.05% - Quiver Quantitative
HIMS Stock Has Quadrupled In 5 Years: How Hims Turned A $3 Stock Into A Telehealth Giant - Stocktwits
Hims & Hers Stock (HIMS) Opinions on Five-Year Public Listing Anniversary - Quiver Quantitative
Financial Markets Wall Street - Dayton Daily News
Kaplan Fox Alerts Investors of Hims & Hers Health, Inc. (NYSE: HIMS) to Possible Securities Law Violations - The National Law Review
HIMS Stock Snaps 2-Day Climb: Analyst Says Record Subscriber Growth ‘Not Enough’ To Offset Margin Slide - Stocktwits
5 Revealing Analyst Questions From Hims & Hers Health’s Q2 Earnings Call - Yahoo Finance
HIMS Stock Climbs Overnight: Oscar Health CEO Courts Hims For New Drug Marketplace - Stocktwits
Citi Says Hims & Hers’ Full-Year Outlook Indicates ‘Hefty’ Q4 Earnings Lift, Warns Of Execution Risks - Stocktwits
Hims & Hers Health (NYSE:HIMS) Upgraded to Hold at Wall Street Zen - MarketBeat
Hims & Hers Health, Inc. • Robinhood Token Price, HIMS Price, Live Charts, and Marketcap - Coinbase
Hims & Hers Health CTO Mohamed Elshenawy Awarded 1.2 Million RSUs - Kalkine Media
Hims & Hers Health Director Christopher D. Payne Awarded 8,768 RSUs in August 2026 - Kalkine Media
Hims & Hers (HIMS) Raised Guidance. Can Growth Survive Its GLP-1 Margin Reset? - Yahoo Finance
Hims & Hers Health raises 2023 revenue outlook after strong Q2 growth despite margin drop - pluang.com
Hims & Hers Health's Next Act: Making Its Own Drugs Again (NYSE:HIMS) - Seeking Alpha
Investor relations - HIMS investor relations
Kaplan Fox Reminds Investors of Hims & Hers Health, Inc. (NYSE: H - The National Law Review
Hims & Hers Health Inc (HIMS) Shares Fall 4.0% -- What GF Score of 78 Tells Investors - GuruFocus
Kaplan Fox is Investigating Hims & Hers Health, Inc. (NYSE: HIMS) for Potential Securities Law Violations - The National Law Review
HIMS Q2 Deep Dive: AI Strategy and International Expansion Shape Telehealth Outlook - Yahoo Finance
HIMS Investigation: Kessler Topaz Meltzer & Check, LLP - GlobeNewswire
Utah sues Hims over alleged 'subscription trap,' sharing of private health data - St. George News
Securities Fraud Investigation Into Hims & Hers Health, - GlobeNewswire
2.00%
0.49%
大文字化:
|
ボリューム (24 時間):